Article info

Download PDFPDF

Safety of the first dose of mRNA SARS-CoV-2 vaccines in patients with rheumatic and musculoskeletal diseases
Free

Authors

  1. Correspondence to Dr Caoilfhionn M Connolly, Rheumatology, Johns Hopkins University, Baltimore, Maryland 21224, USA; connolly{at}jhmi.edu
View Full Text

Citation

Connolly CM, Ruddy JA, Boyarsky BJ, et al
Safety of the first dose of mRNA SARS-CoV-2 vaccines in patients with rheumatic and musculoskeletal diseases

Publication history

  • Received February 23, 2021
  • Revised March 6, 2021
  • Accepted March 9, 2021
  • First published March 19, 2021.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.